4.6 Article

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-Center Experience

Marilyne Daher et al.

Summary: This study reports that the disease burden and clinical outcomes of adrenocortical carcinoma (ACC) have improved over the past two decades. More patients underwent complete surgical resection and received multiple lines of systemic therapy, indicating the importance of these advancements for guiding management strategies.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival

Victor Srougi et al.

Summary: A multicentric, retrospective study compared the impact of cytoreductive surgery on the primary tumor in patients with metastatic ACC, finding that the surgery is associated with prolonged survival. Independent predictors of survival included age, hormone excess, and local metastasis therapy.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Pitfalls and progress in adrenocortical carcinoma diagnosis: the utility of a multidisciplinary approach, immunohistochemistry and genomics

Ray Wang et al.

Summary: Adrenocortical carcinoma is a rare disease with significant clinical heterogeneity, presenting a diagnostic challenge to clinicians. Specialist multidisciplinary team input and genomics play vital roles in diagnosis and prognosis of adrenocortical carcinoma.

ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2022)

Review Endocrinology & Metabolism

A multidisciplinary approach to the management of adrenal incidentaloma

Giacomo Voltan et al.

Summary: This review discusses the characteristics, prevalence, diagnosis, and treatment recommendations for adrenal incidentalomas, with a focus on the multidisciplinary approach and evaluation of malignant and functioning forms of the disease.

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period

F. Ceccato et al.

Summary: The emergency plan tailored for outpatients with endocrine diseases in response to the COVID-19 outbreak in Italy was effective in ensuring continued follow-up care for patients, with 86% of patients contacted receiving a clinical response. The cancellation rate of visits decreased significantly after the implementation of endocrine triage, indicating the plan's usefulness in maintaining continuity of care for outpatients.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Article Urology & Nephrology

Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States

Benjamin V. Stone et al.

Summary: The study found that treatment of adrenocortical carcinoma at an academic center is associated with improved overall survival compared to community programs. Academic centers had more aggressive surgical treatment practices, and the survival benefit persisted even after controlling for treatment modality in multivariable analysis.

JOURNAL OF UROLOGY (2021)

Review Endocrinology & Metabolism

ENSAT registry-based randomized clinical trials for adrenocortical carcinoma

Joakim Crona et al.

Summary: Adrenocortical carcinoma is a rare disease with limited treatment options. Registry-based clinical trials are seen as a cost-effective approach with high scientific potential. ENSAT is considering transforming their current registry into a clinical trial infrastructure to conduct randomized registry-based trials for ACC patients.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

Article Health Care Sciences & Services

What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question

Vittoria Basile et al.

Summary: The study found that extending adjuvant mitotane treatment over two years did not show significant survival advantage in patients with ACC, and the relationship between treatment duration and the frequency of ACC recurrence was not linear.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Endocrinology & Metabolism

Frequently asked questions and answers (if any) in patients with adrenal incidentaloma

F. Ceccato et al.

Summary: Management of adrenal incidentalomas involves excluding malignancy, assessing adrenal hormones, and recommending a personalized diagnostic-therapeutic approach based on multidisciplinary discussion.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Article Oncology

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma

Mouhammed Amir Habra et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Article Oncology

Role of Radiotherapy in Adrenocortical Carcinoma

Jennifer Ho et al.

CANCER JOURNAL (2013)

Article Endocrinology & Metabolism

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center

Montserrat Ayala-Ramirez et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)

Article Endocrinology & Metabolism

Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data

T. M. A. Kerkhofs et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)

Article Endocrinology & Metabolism

Update in Adrenocortical Carcinoma

Martin Fassnacht et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Review Cell Biology

Molecular epidemiology of adrenocortical tumors in southern Brazil

Gislaine Custodio et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)

Review Oncology

Quality of Care Management Decisions by Multidisciplinary Cancer Teams: A Systematic Review

Benjamin W. Lamb et al.

ANNALS OF SURGICAL ONCOLOGY (2011)

Article Endocrinology & Metabolism

Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists

Mabrouka Doghman et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Medicine, General & Internal

Adjuvant mitotane treatment for adrenocortical carcinoma

Massimo Terzolo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Endocrinology & Metabolism

A survey on adrenal incidentaloma in Italy

F Mantero et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)